Benefits of insulin detemir over NPH insulin in children and adolescents with Type 1 diabetes:: Lower and more predictable fasting plasma glucose and lower risk of nocturnal hypoglycaemia

被引：0
|
作者：
Robertson, KJ
Schönle, E
Gucev, Z
Mordhorst, L
Tamer, SC
Gall, MA
Ludvigsson, J
机构：
[1] Royal Hosp Sick Children, Glasgow G3 8SJ, Lanark, Scotland
[2] Univ Childrens Hosp, Zurich, Switzerland
[3] Clin Childrens Dis, Dept Endocrinol & Genet, Skopje, Macedonia
[4] Novo Nordisk AS, Trial Management Diabet, DK-2880 Bagsvaerd, Denmark
[5] Novo Nordisk AS, Clin Stat, DK-2880 Bagsvaerd, Denmark
[6] Novo Nordisk AS, Diabet Therapy Area, DK-2880 Bagsvaerd, Denmark
[7] Linkoping Univ Hosp, Div Paediat, S-58185 Linkoping, Sweden
来源：
DIABETOLOGIA | 2004年 / 47卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
81
引用
收藏
页码：A32 / A32
页数：1
相关论文
共 50 条
  • [1] Benefits of insulin detemir over NPH insulin in children and adolescents with type 1 diabetes:: Lower and more predictable fasting plasma glucose and lower risk of nocturnal hypoglycemia
    Robertson, K
    Schönle, E
    Gucev, Z
    Mordhorst, L
    Tamer, SC
    Gall, MA
    Ludvigsson, J
    [J]. DIABETES, 2004, 53 : A144 - A144
  • [2] Lower and more predictable fasting blood glucose and reduced risk of nocturnal hypoglycaemia with once daily insulin detemir versus NPH in subjects with Type 1 diabetes
    Russell-Jones, D
    Bolinder, J
    Simpson, R
    [J]. DIABETOLOGIA, 2002, 45 : A51 - A51
  • [3] Insulin detemir is associated with more predictable glycemic control and lower risk of hypoglycemia compared to NPH insulin in subjects with type 1 diabetes
    Vague, P
    Selam, JL
    Skeie, S
    De Leeuw, I
    Willem, J
    Elte, F
    Haahr, H
    Kristensen, A
    Draeger, E
    [J]. DIABETES, 2002, 51 : A116 - A117
  • [4] Insulin detemir lowers the risk of hypoglycaemia and provides more consistent plasma glucose levels compared with NPH insulin in Type 1 diabetes
    Kolendorf, K.
    Ross, G. P.
    Pavlic-Renar, I.
    Perriello, G.
    Philotheou, A.
    Jendle, J.
    Gall, M-A.
    Heller, S. R.
    [J]. DIABETIC MEDICINE, 2006, 23 (07) : 729 - 735
  • [5] Lower fasting blood glucose, glucose variability and nocturnal hypoglycaemia with glargine vs NPH basal insulin in subjects with Type 1 diabetes
    Bolli, G. B.
    Songini, M.
    Trovati, M.
    Del Prato, S.
    Ghirlanda, G.
    Cordera, R.
    Trevisan, R.
    Riccardi, G.
    Noacco, C.
    [J]. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2009, 19 (08) : 571 - 579
  • [6] Insulin detemir achieves lower, less variable fasting glucose and a reduced risk of nocturnal hypoglycaemia and weight gain compared to NPH insulin in basal bolus therapy of Japanese patients with type 1 diabetes
    Kobayashi, M.
    Iwamoto, Y.
    Kawamori, R.
    Tajima, N.
    Nishida, T.
    Kaku, K.
    [J]. DIABETOLOGIA, 2006, 49 : 608 - 609
  • [7] Insulin detemir compared with NPH insulin in children and adolescents with Type 1 diabetes
    Robertson, K. J.
    Schoenle, E.
    Gucev, Z.
    Mordhorst, L.
    Gall, M. -A.
    Ludvigsson, J.
    [J]. DIABETIC MEDICINE, 2007, 24 (01) : 27 - 34
  • [8] Lower rate of hypoglycaemia but comparable glycaemic control with insulin detemir compared to NPH insulin in patients with type 1 diabetes
    Hermansen, K.
    Heller, S.
    Andersen, M.
    Russell-Jones, D. L.
    [J]. DIABETOLOGIA, 2009, 52 : S359 - S359
  • [9] Insulin detemir is associated with lower risk of hypoglycemia compared to NPH insulin in people with Type 1 diabetes
    Kolendorf, K
    Prasek, M
    Santeusanio, F
    Philotheou, A
    Gall, MA
    Heller, S
    [J]. DIABETOLOGIA, 2004, 47 : A329 - A329
  • [10] Insulin detemir is associated with lower risk of hypoglycemia compared to NPH insulin in people with type 1 diabetes
    Kolendorf, K
    Pavlic-Renar, I
    San-Teusanio, F
    Philotheou, A
    Gall, MA
    Heller, S
    [J]. DIABETES, 2004, 53 : A130 - A131
12345